Matsuoka K, Watanabe M, Ohmori T, Nakajima K, et al. AJM300 (carotegrast methyl), an oral antagonist of alpha4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. Lancet Gastroenterol Hepatol 2022 Mar 30. pii: S2468-1253(22)00022.
PMID: 35366419